It has been reported that SMAD4 acts as a prognostic biomarker in various human malignancies such as colorectal carcinoma [40] and pancreatic carcinoma [41], but its role as a prognostic marker in breast carcinoma is still unclear [42]. The gene discussed is SMAD4; the disease is breast carcinoma.